- Revenue
- $200M
- Customers
- 850M
- Year founded
- 2012
- Funding
- $411.9M
- Team size
- 793
Top 1 Pharma and Biotech Software Companies $100M+ Revenue (August 2026)
As of August 2026, Latka tracks 1 pharma and biotech software companies with $100M+ in annual revenue. They have combined revenues of $200M and employ 793 people. They have raised $411.9M and serve 850M customers combined.
Every company below sells pharma and biotech software to other businesses and is ranked by its most recent annual revenue. Revenue, funding, headcount and customer figures come from CEO interviews on the Latka podcast, public company filings, and Latka estimates where a company has not disclosed a number.
What Pharma and Biotech Software Companies do
Pharma and Biotech Software encompasses a range of software solutions specifically designed to meet the needs of the pharmaceutical and biotechnology industries. These tools facilitate activities such as drug discovery, development, regulatory compliance, clinical trials, and post-market surveillance. By streamlining workflows and improving data management, these software solutions can enhance productivity and support the innovation process within these highly regulated sectors. Typical features of Pharma and Biotech Software include data analytics, laboratory information management systems (LIMS), electronic lab notebooks (ELN), clinical trial management systems (CTMS), and regulatory compliance tools. Users commonly include researchers, clinical trial managers, regulatory affairs professionals, and quality assurance teams, all focused on ensuring that products meet rigorous standards for safety and efficacy. As the industry continues to evolve, there is a growing emphasis on integrating advanced technologies such as artificial intelligence and machine learning to improve decision-making processes and accelerate drug development timelines. These innovations not only help organizations maintain competitiveness but also foster collaboration across various departments and stakeholders involved in the drug development lifecycle.
- Companies
- 1
- Revenue
- $200M
- Funding
- $411.9M
- Employees
- 793
Filters
Sorting: Highest -> Lowest
Top Pharma and Biotech Software Companies $100M+ Revenue
Showing 1 of 1 companies ranked by annual revenue.
Frequently asked questions about Pharma and Biotech Software Companies $100M+ Revenue
How many pharma and biotech software companies with $100M+ in annual revenue are there?
Latka tracks 1 pharma and biotech software companies with $100M+ in annual revenue. Together they generate $200M in annual revenue and employ 793 people.
Which pharma and biotech software company with $100M+ in annual revenue is the largest?
Benchling is the largest, with $200M in annual revenue, founded in 2012.
How much revenue does a typical pharma and biotech software company with $100M+ in annual revenue make?
The average pharma and biotech software company in this list makes $200M a year, across 1 companies with reported revenue. They serve 850M customers combined.
Who are the leading Pharma and Biotech software vendors with $100M+ in annual revenue?
Ranked by annual revenue, the leaders are Benchling.
How much funding have pharma and biotech software companies with $100M+ in annual revenue raised?
The 1 pharma and biotech software companies with $100M+ in annual revenue tracked here have raised $411.9M in disclosed funding between them.
Related Vertical Industry Software categories
Inclusion Criteria
- Software must support drug discovery and development processes. - Must provide tools for regulatory compliance and quality assurance. - Should enable efficient data management and analytics capabilities. - Must cater to end users such as researchers, clinical trial managers, and regulatory professionals. - Not just focus on general business functions; must cater specifically to pharma and biotech workflows.